Vit B12
Hyperhomocysteinemia
Center for Health Sciences, SerbiaPhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 49/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Hyperhomocysteinemia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Folic Acid Shenzhen Ausa Pharmed Co.,Ltd | Phase 4 | BBB |
Folate Universidade Estadual de Londrina | Phase 4 | BB |
Hydrochlorothiazide Second Affiliated Hospital of Nanchang University | Phase 4 | BB |
Vitamin B6 Center for Health Sciences, Serbia | Phase 3 | BB |
Cystadane Center for Health Sciences, Serbia | Phase 3 | BB |
View all 11 →
Same molecule, other indications
Vit B12 is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →